Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
about
Combined oral contraceptives: venous thrombosisCombined oral contraceptives: venous thrombosisAssessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysisDifferent combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisThe Danish National Patient Registry: a review of content, data quality, and research potentialContraception and cardiovascular diseaseHormonal contraception and venous thromboembolismVenous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10Hormonal anticonception anno 2013: a clinician's viewDrospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia.Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.Computer-assisted provision of hormonal contraception in acute care settingsMultinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.Prevention and treatment of venous thromboembolism during HRT: current perspectives.Epidemiology, risk factors and sequelae of venous thromboembolism.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsHirsutism: an evidence-based treatment update.Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical PharmacologyDrospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS).Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in FranceOral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.Polycystic ovary syndrome: chemical pharmacotherapy.Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesThe Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.Progestin-only contraceptive pill use among women in the United States.Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study.Risks of venous thromboembolism with various hormonal contraceptives.Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.Comorbidity in patients with branch retinal vein occlusion: case-control study.Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysisHospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia.Commentary on hormonal contraceptive use in Ireland: trends and co-prescribing practices.Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy useControl of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Life-threatening complications of hormonal contraceptives: a case historyImpact of the 2013 French Pill Crisis on Women's Behaviour Regarding Contraception
P2860
Q24198113-8B781CC7-23A6-49BE-B27C-BC4B95F4896BQ24202769-11DD3C22-1706-469C-9176-2DD503F2A111Q24622035-3FB17C4F-AB67-4528-9373-3950529209C2Q24624180-61E21A8C-E7E4-4636-8405-0593557D1851Q26775834-2F5A77F9-0A1B-4BF1-B129-720759347873Q27026895-7ABEDE76-8C6C-47B6-B5D2-C4137AEF29D0Q28266187-23538395-2E25-49F0-A16E-C0A76B6395FBQ28266410-6BFABD0F-F626-486E-AC36-AF2E0EFCCD7EQ28384050-C9494A51-4B9F-4729-AFAD-A66E595DDDBAQ30235365-4D38D2FD-B892-404D-A734-69F5DF072F24Q33166310-3AB38942-B157-40DA-9859-FABCDC4A9EFEQ33728471-79E4D604-7E6F-46B7-8FBB-2720920C0922Q33776320-27B91F00-EBAD-4A17-B237-C0696A167730Q34050164-F636069D-B0F9-498A-9A27-D6387D88097DQ34140721-FB7F5DE7-E5E2-4156-92CE-F6262833D684Q34264218-4B97B910-F9F1-4FBC-9603-9402A67ED956Q34317537-6BC03CC5-B7DE-4E8C-AFDF-6351BE20C0A1Q34422575-99E58BFD-CFE4-4E3E-8BCD-624C7F79EE69Q34588375-F0524FD9-8162-4234-B4C5-32EF98FB152FQ34636421-33683E52-3167-40B2-A768-4A5FA9EEE96BQ35091611-1DECF7F8-96CD-4549-AC9D-C84B1C122ADAQ35135876-4D8CD108-CC74-4C13-A3A4-C5FF3A04D998Q35153912-61BF9BB3-C0BE-4015-B03C-636874C89B5CQ35312383-0B8404EB-1D8A-4BB8-9F41-BE8067F7D359Q35639510-92F8D029-8CF7-48F9-B5C9-631A0FACE32BQ35651010-DD480372-AA79-4564-9524-B594286CE47CQ36188259-8A85B6A1-DED9-4866-9EAC-DA806C53049FQ36230073-865F6D09-9B93-4BE3-9055-0634328272D3Q36302904-E4FBE51D-AF18-4C63-9680-BE0AFB711FDDQ36314893-D196DBB7-432C-43D7-940D-F452D25A124CQ36357292-6B359320-79FB-4CCF-8587-025A97970A01Q36435951-4D669329-680E-413A-A6A8-B05E86D5C0A8Q36586257-F716CD1E-DDBA-475F-A647-58278F0F2EB6Q36662483-DA2E35E5-00FD-487C-9EAF-18A1ED6B36AEQ36706815-2C79917F-6976-40B0-A10E-FEF296802DDDQ36800361-7B085D88-257C-479C-9893-B10CF52E05ABQ36850156-70E0A3F3-AB68-49BB-86DB-1E7EAC73ECE1Q36887503-4D55E37C-2EA8-4079-B818-F09B9BF4E5EAQ36899443-612486E9-03DE-480D-BCE6-960F347ADF87Q36942841-3CD2E55D-00AA-4AC1-A64D-9F35AD3597A4
P2860
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@ast
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@en
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@nl
type
label
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@ast
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@en
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@nl
prefLabel
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@ast
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@en
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@nl
P2093
P2860
P3181
P356
P1433
P1476
Risk of venous thromboembolism ...... s: Danish cohort study, 2001-9
@en
P2093
Charlotte Wessel Skovlund
Lars Hougaard Nielsen
Øjvind Lidegaard
P2860
P3181
P356
10.1136/BMJ.D6423
P407
P433
P5008
P577
2011-01-01T00:00:00Z